Search This Blog

Tuesday, November 12, 2019

SpringWorks Therapeutics EPS misses by $1.29

SpringWorks Therapeutics (NASDAQ:SWTX): Q3 GAAP EPS of -$1.77 misses by $1.29.
Cash and equivalents of $343.83M

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.